欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Tyrosine Kinase-Anaplastic Lymphoma Kinase (ALK)-NVL-655
NVL-655

Chemical Structure : NVL-655

CAS No.: 2739866-40-9

NVL-655 (Neladalkib, NVL655)

货号: PC-23342Not For Human Use, Lab Use Only.

Neladalkib (NVL-655) is a potent, selective and brain-penetrant fourth-generation inhibitor of diverse ALK-mutant oncoproteins with IC50 of 0.9 nM and 1.8 nM for WT ALK and ALK G1202R/L1196M mutant respectively.

规格 价格 库存 数量
5 mg ¥780 In stock
10 mg ¥1180 In stock
25 mg ¥2180 In stock
50 mg ¥3480 In stock
100 mg ¥5480 In stock
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Neladalkib (NVL-655) is a potent, selective and brain-penetrant fourth-generation inhibitor of diverse ALK-mutant oncoproteins with IC50 of 0.9 nM and 1.8 nM for WT ALK and ALK G1202R/L1196M mutant respectively.
Neladalkib (NVL-655) potently inhibits cell lines expressing WT ALK fusions with average IC50 < 1.1 nM.
Neladalkib (NVL-655) exhibits an IC50 of 0.3 to 1.6 nM against MGH048-1, MGH064-1, and MGH026-1 cell lines, which were established from TKI-naïve patients with NSCLC harboring EML4–ALK v1, v2, and v3 fusions, respectively, and IC50 of 2 nM against the anaplastic large cell lymphoma cell line Karpas299 harboring the NPM1–ALK fusion.
Neladalkib (NVL-655) potently inhibits the growth of cell lines harboring ALKG1202R fusions (IC50 = 0.1–0.8 nmol/L, average
< 0.3 nM), including three PDCs established after progressive disease on alectinib (MGH953-4 and YU1077) or brigatinib (MGH9037-2).
Neladalkib (NVL-655) is >14-fold more potent than zotizalkib, >100 fold more potent than lorlatinib, and >280-fold more potent
than 1G and 2G ALK TKIs on average.
Neladalkib (NVL-655) inhibits ALK over TRK with 22-fold to >874-fold selectivity.
Neladalkib (NVL-655) demonstrates preliminary proof-of-concept clinical activity in heavily pretreated patients with ALK fusion-positive non-small cell lung cancer, including in patients with brain metastases and single or compound ALK resistance mutations.

物理化学性质&存储条件

分子量 452.92
分子式 C23H22ClFN6O
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(R)-1-Chloro-3-ethyl-12-fluoro-10,16-dimethyl-3,10,16,18-tetrahydro-4,8-(metheno)benzo[l]dipyrazolo[3,4-g:4',3'-j][1]oxa[4]azacyclotetradecin-7-amine

参考文献

1. Lin JJ, et al. Cancer Discov. 2024 Sep 13:OF1-OF20.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: